Anti-CDO1 antibody (1-200) (STJ110700)

SKU:
STJ110700

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-CDO1 (1-200) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: CDO1
Gene ID: 1036
Uniprot ID: CDO1_HUMAN
Immunogen Region: 1-200
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-200 of human CDO1 (NP_001792.2).
Immunogen Sequence: MEQTEVLKPRTLADLIRILH QLFAGDEVNVEEVQAIMEAY ESDPTEWAMYAKFDQYRYTR NLVDQGNGKFNLMILCWGEG HGSSIHDHTNSHCFLKMLQG NLKETLFAWPDKKSNEMVKK SERVLRENQCAYINDSIGLH RVENISHTEPAVSLHLYSPP FDTCHAFDQRTGHKNKVTMT FHSKFGIRTPNATSGSLENN
Tissue Specificity Highly expressed in liver and placenta. Low expression in heart, brain and pancreas. Also detected in hepatoblastoma Hep-G2 cells.
Post Translational Modifications The thioether cross-link between Cys-93 and Tyr-157 plays a structural role through stabilizing the Fe(2+) ion, and prevents the production of highly damaging free hydroxyl radicals by holding the oxygen radical via hydroxyl hydrogen.
Function Catalyzes the oxidation of cysteine to cysteine sulfinic acid with addition of molecular dioxygen.
Protein Name Cysteine Dioxygenase Type 1
Cysteine Dioxygenase Type I
Cdo
Cdo-I
Database Links Reactome: R-HSA-1614558
Alternative Antibody Names Anti-Cysteine Dioxygenase Type 1 antibody
Anti-Cysteine Dioxygenase Type I antibody
Anti-Cdo antibody
Anti-Cdo-I antibody
Anti-CDO1 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance